Skip to main content
Premium Trial:

Request an Annual Quote

Selah Genomics Licenses UniConnect's LIMS to Support Clinical MDx Services

Premium

Selah Genomics has licensed UniFlow, UniConnect's laboratory information management system, to manage molecular and clinical data for its clinical diagnostic services business.

Michael Bolick, Selah's co-founder and CEO, said in a statement that his firm chose UniFlow because it met his firm's need for a "purpose-built" LIMS software solution, "not one that was just retrofitted for our arena."

Among other capabilities, UniFlow tracks and manages processes involving multiple steps and information types, such as samples, outputs, instruments, reagents, worker responsibilities, and requests. Also, users can customize the system to their needs and modify them as requirements change.

Besides Selah, UniFlow being used by Vivia Biotech, a Sergovia, Spain-based personalized medicine firm (BI 5/27/2011), and Dupont Pioneer (BI 5/3/2013).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.